tiprankstipranks
Advertisement
Advertisement

ASMB Stock Latest News

Assembly Biosciences price target raised to $43 from $39 at Guggenheim
The FlyAssembly Biosciences price target raised to $43 from $39 at Guggenheim
2d ago
ASMB
GILD
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
PremiumCompany Announcements
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
9d ago
8K
ASMB
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
PremiumCompany Announcements
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
16d ago
ASMB
Assembly Biosciences files $400M mixed securities shelf
PremiumThe Fly
Assembly Biosciences files $400M mixed securities shelf
20d ago
ASMB
Is ASMB a Buy, Before Earnings?
PremiumPre-Earnings
Is ASMB a Buy, Before Earnings?
1M ago
ASMB
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
PremiumRatingsGilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
4M ago
ASMB
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
Premium
The Fly
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
4M ago
ASMB
GILD
Gilead exercises option to license Assembly helicase-primase inhibitor programs
Premium
The Fly
Gilead exercises option to license Assembly helicase-primase inhibitor programs
4M ago
ASMB
GILD
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
PremiumCompany Announcements
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
4M ago
ASMB
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
PremiumRatings
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
4M ago
ASMB
Assembly Biosciences Reports Positive Phase 1b Results
PremiumCompany Announcements
Assembly Biosciences Reports Positive Phase 1b Results
4M ago
8K
ASMB
Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials
PremiumThe Fly
Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials
4M ago
ASMB
GILD
Assembly Biosciences price target raised to $40 from $29 at Mizuho
PremiumThe FlyAssembly Biosciences price target raised to $40 from $29 at Mizuho
5M ago
ASMB
Assembly Biosciences: Strong Clinical Execution and Strategic Partnerships Drive Buy Rating
Premium
Ratings
Assembly Biosciences: Strong Clinical Execution and Strategic Partnerships Drive Buy Rating
5M ago
ASMB
Assembly Biosciences Inc. Reports Q3 2025 Earnings
Premium
Company Announcements
Assembly Biosciences Inc. Reports Q3 2025 Earnings
5M ago
ASMB
Assembly Biosciences reports Q3 EPS (72c), consensus (65c)
PremiumThe Fly
Assembly Biosciences reports Q3 EPS (72c), consensus (65c)
5M ago
ASMB
Assembly Biosciences announces Phase 1b data for ABI-4334
PremiumThe Fly
Assembly Biosciences announces Phase 1b data for ABI-4334
5M ago
ASMB
ASMB Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ASMB Earnings this Week: How Will it Perform?
5M ago
ASMB
Assembly Biosciences Advances HSV-2 Treatment Study with ABI-1179
PremiumCompany Announcements
Assembly Biosciences Advances HSV-2 Treatment Study with ABI-1179
5M ago
ASMB
Assembly Biosciences’ Promising HSV-2 Treatment Study: Key Insights for Investors
PremiumCompany AnnouncementsAssembly Biosciences’ Promising HSV-2 Treatment Study: Key Insights for Investors
5M ago
ASMB
Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment
Premium
Company Announcements
Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment
5M ago
ASMB
Assembly Biosciences files to sell 6.98M shares of commons stock for holders
Premium
The Fly
Assembly Biosciences files to sell 6.98M shares of commons stock for holders
6M ago
ASMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >